These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 32948372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.
    Int J Drug Policy; 2024 Sep; 131():104547. PubMed ID: 39159532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
    Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R.
    Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R.
    Harm Reduct J; 2020 Mar 30; 17(1):23. PubMed ID: 32228646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
    Fleming T, Barker A, Ivsins A, Vakharia S, McNeil R.
    Harm Reduct J; 2020 Jan 10; 17(1):6. PubMed ID: 31924209
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G, Bowles JM, Mansoor M, Werb D, Kerr T.
    Subst Abuse Treat Prev Policy; 2023 Mar 03; 18(1):14. PubMed ID: 36869358
    [Abstract] [Full Text] [Related]

  • 17. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, Arnold EA.
    Harm Reduct J; 2024 May 11; 21(1):92. PubMed ID: 38734643
    [Abstract] [Full Text] [Related]

  • 18. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP, Goldman JE, Yedinak JL, Bernstein E, Hadland SE, Buxton JA, Sherman SG, Biello KB, Marshall BDL.
    Trials; 2020 Nov 26; 21(1):976. PubMed ID: 33243291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N, McDonald K, Stefan C, Beriault DR, Mason K, Barnaby L, Altenberg J, MacDonald RD, Caldwell J, Nisenbaum R, Leece P, Watson TM, Tupper KW, Kufner L, Scheim AI, Werb D, Drug Checking Services in Toronto Working Group.
    Harm Reduct J; 2020 Jan 28; 17(1):9. PubMed ID: 32204713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.